Literature DB >> 14674691

Inactivation of acetylcholinesterase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride.

Lun-Yi Zang1, Hara P Misra.   

Abstract

The neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) has been shown to reversibly inhibit the activity of acetylcholinesterase. The inactivation of the enzyme was detected by monitoring the accumulation of yellow color produced from the reaction between thiocholine and dithiobisnitrobenzoate ion. The kinetic parameter, Km for the substrate (acetylthiocholine), was found to be 0.216 mM and Ki for MPTP inactivation of acetylcholinesterase was found to be 2.14 mM. The inactivation of enzyme by MPTP was found to be dose-dependent. It was found that MPTP is neither a substrate of AChE nor the time-dependent inactivator. The studies of reaction kinetics indicate the inactivation of AChE to be a linear mixed-type inhibition. The dilution assays indicate that MPTP is a reversible inhibitor for AChE. These data suggest that once MPTP enters the basal ganglia of the brain, it can inactivate the acetylcholinesterase enzyme and thereby increase the acetylcholine level in the basal ganglia of brain, leading to potential cell dysfunction. It appears that the nigrostriatal toxicity by MPTP leading to Parkinson's disease-like syndrome may, in part, be mediated via the acetylcholinesterase inactivation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14674691     DOI: 10.1023/a:1027376303043

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  Structure and dynamics of serine hydrolase-organophosphate adducts.

Authors:  I M Kovach
Journal:  J Enzyme Inhib       Date:  1988

2.  Kinetics for the inhibition of acetylcholinesterase from the electric eel by some organophosphates and carbamates.

Authors:  A Forsberg; G Puu
Journal:  Eur J Biochem       Date:  1984-04-02

3.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

Authors:  K Chiba; A Trevor; N Castagnoli
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

4.  Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  K Chiba; L A Peterson; K P Castagnoli; A J Trevor; N Castagnoli
Journal:  Drug Metab Dispos       Date:  1985 May-Jun       Impact factor: 3.922

5.  Acetylcholinesterase inhibition by 1-methyl-4-phenylpyridinium ion, a bioactivated metabolite of MPTP.

Authors:  L Y Zang; H P Misra
Journal:  Mol Cell Biochem       Date:  1993-09-22       Impact factor: 3.396

6.  Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  L Y Zang; H P Misra
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

7.  Superoxide radical production during the autoxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium perchlorate.

Authors:  L Y Zang; H P Misra
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

Review 8.  Modulation of peripheral sympathetic nerve transmission.

Authors:  G S Francis
Journal:  J Am Coll Cardiol       Date:  1988-07       Impact factor: 24.094

9.  Stereospecific reactivation of human brain and erythrocyte acetylcholinesterase inhibited by 1,2,2-trimethylpropyl methylphosphonofluoridate (soman).

Authors:  L P de Jong; S P Kossen
Journal:  Biochim Biophys Acta       Date:  1985-08-23

10.  Phenothiazines inhibit acetylcholinesterase by concentration-dependent-type kinetics. A study with trifluoperazine and perphenazine.

Authors:  A Spinedi; L Pacini; C Limatola; P Luly; R N Farias
Journal:  Biochem Pharmacol       Date:  1992-10-20       Impact factor: 5.858

View more
  2 in total

Review 1.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

2.  Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model.

Authors:  Xu Zhang; Jian-Ying Zhou; Mark H Chin; Athena A Schepmoes; Vladislav A Petyuk; Karl K Weitz; Brianne O Petritis; Matthew E Monroe; David G Camp; Stephen A Wood; William P Melega; Diana J Bigelow; Desmond J Smith; Wei-Jun Qian; Richard D Smith
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.